Biallelicmutations in BRCA2 (also known as FANCD1) areidentified in around 3-5% of FA cases and are associated with a high risk ofaggressive embryonal tumors in early childhood stages (mostly medulloblastomas andnephroblastomas) and/or acute leukemia (Reidet al., 2005; Meyeret al., 2014). This evidence concerns the gene BRCA2 and acute leukemia.